SCHEMBL19997408

SCHEMBL19997408

COc1nc(S(C)(=O)=O)nn2c([C@@]3(O)O[C@H](COCc4ccccc4)[C@@H](OCc4ccccc4)[C@@]3(C)OCc3ccccc3)cnc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12393239 1.00 — —
SCHEMBL12243231 0.91 HSPA5 (0.33) —
SCHEMBL12393241 0.88 HSPA5 (0.34) —
SCHEMBL14038962 0.86 TP53 (0.30) —
SCHEMBL19997394 0.82 — —
SCHEMBL23278056 0.82 HSPA5 (0.32) —
SCHEMBL2374198 0.81 HSPA5 (0.35) —
SCHEMBL12243232 0.81 HSPA5 (0.35) —
SCHEMBL19997429 0.81 HSPA5 (0.35) —
SCHEMBL12243233 0.80 PDE2A (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE46762-E1 1′-substituted carba-nucleoside analogs for antiviral treatment GILEAD SCIENCES, INC (US) 2018-03-27 — — US disclosed
Send feedback